BCA-1/BLC (CXCL13), human recombinant protein
B cell Attracting Chemokine-1, CXCL13, BLC (mouse), BLR1 Ligand
|Calculated MW||10.1 kDa|
|Other Names||B cell Attracting Chemokine-1, CXCL13, BLC (mouse), BLR1 Ligand, Angie, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13|
|Application Notes||Centrifuge the vial prior to opening. Reconstitute in H₂O to a concentration of 0.1-1 mg/ml. The solution can then be diluted into other aqueous buffers or store at 4°C for 1 week or -20°C for future use.|
|Storage||-20°C; Sterile filtered and lyophilized from 10 mM TFA|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Human BCA-1 (B Cell-Attracting chemokine 1), also known as BLC or CXCL13, is a recently identified new CXC chemokines. Human BCA-1 is a highly effective attractant for human blood B lymphocytes, but was inactive on freshly isolated or IL-2 stimulated T lymphocytes, monocytes and neutrophils. The human BCA-1 is a 10.1 kDa protein containing 85 amino acid residues.
Gunn M.D.,et al.Nature 391:799-803(1998).
Legler D.F.,et al.J. Exp. Med. 187:655-660(1998).
Napolitano M.,et al.Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
If you have any additional inquiries please email technical services at email@example.com.